ArticleCancers2020

Circulating Interleukin-4 Is Associated with a Systemic T Cell Response against Tumor-Associated Antigens in Treatment-Naïve Patients with Resectable Non-Small-Cell Lung Cancer.

Seyer Safi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.